147 related articles for article (PubMed ID: 36991394)
1. Post introduction evaluation of the malaria vaccine implementation programme in Ghana, 2021.
Adjei MR; Amponsa-Achiano K; Okine R; Tweneboah PO; Sally ET; Dadzie JF; Osei-Sarpong F; Adjabeng MJ; Bawa JT; Bonsu G; Antwi-Agyei KO; Kaburi BB; Owusu-Antwi F; Juma E; Kasolo FC; Asiedu-Bekoe F; Kuma-Aboagye P
BMC Public Health; 2023 Mar; 23(1):586. PubMed ID: 36991394
[TBL] [Abstract][Full Text] [Related]
2. Challenges and lessons learned during the planning and early implementation of the RTS,S/AS01
Grant J; Gyan T; Agbokey F; Webster J; Greenwood B; Asante KP
Malar J; 2022 May; 21(1):147. PubMed ID: 35550113
[TBL] [Abstract][Full Text] [Related]
3. Assessing the safety, impact and effectiveness of RTS,S/AS01
Praet N; Asante KP; Bozonnat MC; Akité EJ; Ansah PO; Baril L; Boahen O; Mendoza YG; Haine V; Kariuki S; Lamy M; Maleta K; Mungwira R; Ndeketa L; Oduro A; Ogutu B; Olewe F; Oneko M; Orsini M; Roman F; Bahmanyar ER; Rosillon D; Schuerman L; Sing'oei V; Terlouw DJ; Wéry S; Otieno W; Pirçon JY
Malar J; 2022 Apr; 21(1):132. PubMed ID: 35468801
[TBL] [Abstract][Full Text] [Related]
4. Feasibility, safety, and impact of the RTS,S/AS01
Asante KP; Mathanga DP; Milligan P; Akech S; Oduro A; Mwapasa V; Moore KA; Kwambai TK; Hamel MJ; Gyan T; Westercamp N; Kapito-Tembo A; Njuguna P; Ansong D; Kariuki S; Mvalo T; Snell P; Schellenberg D; Welega P; Otieno L; Chimala A; Afari EA; Bejon P; Maleta K; Agbenyega T; Snow RW; Zulu M; Chinkhumba J; Samuels AM;
Lancet; 2024 Apr; 403(10437):1660-1670. PubMed ID: 38583454
[TBL] [Abstract][Full Text] [Related]
5. Predictors of malaria vaccine uptake among children 6-24 months in the Kassena Nankana Municipality in the Upper East Region of Ghana.
Yeboah D; Owusu-Marfo J; Agyeman YN
Malar J; 2022 Nov; 21(1):339. PubMed ID: 36384655
[TBL] [Abstract][Full Text] [Related]
6. RTS,S/AS01 malaria vaccine pilot implementation in western Kenya: a qualitative longitudinal study to understand immunisation barriers and optimise uptake.
Hoyt J; Okello G; Bange T; Kariuki S; Jalloh MF; Webster J; Hill J
BMC Public Health; 2023 Nov; 23(1):2283. PubMed ID: 37980467
[TBL] [Abstract][Full Text] [Related]
7. "I would have to sell things in order to get the money": A qualitative exploration of willingness to pay for the RTS,S/AS01 malaria vaccine in the Volta region, Ghana.
Darkwa S; de Wildt G; Dalaba M; Vidzro E; Ansah EK
PLoS One; 2022; 17(6):e0268009. PubMed ID: 35675273
[TBL] [Abstract][Full Text] [Related]
8. Barriers and facilitators to nationwide implementation of the malaria vaccine in Ghana.
Adeshina OO; Nyame S; Milner J; Milojevic A; Asante KP
Health Policy Plan; 2023 Jan; 38(1):28-37. PubMed ID: 36083007
[TBL] [Abstract][Full Text] [Related]
9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
10. Costs of continuing RTS,S/ASO1E malaria vaccination in the three malaria vaccine pilot implementation countries.
Baral R; Levin A; Odero C; Pecenka C; Tabu C; Mwendo E; Bonsu G; Bawa J; Dadzie JF; Charo J; Antwi-Agyei KO; Amponsa-Achianou K; Jalango RE; Mkisi R; Gordon S; Mzengeza T; Morgan W; Muhib F
PLoS One; 2021; 16(1):e0244995. PubMed ID: 33428635
[TBL] [Abstract][Full Text] [Related]
11. Cost of introducing and delivering RTS,S/AS01 malaria vaccine within the malaria vaccine implementation program.
Baral R; Levin A; Odero C; Pecenka C; Tanko Bawa J; Antwi-Agyei KO; Amponsa-Achaino K; Chisema MN; Eddah Jalango R; Mkisi R; Gordon S; Morgan W; Muhib F
Vaccine; 2023 Feb; 41(8):1496-1502. PubMed ID: 36710234
[TBL] [Abstract][Full Text] [Related]
12. Community perceptions of a malaria vaccine in the Kintampo districts of Ghana.
Febir LG; Asante KP; Dzorgbo DB; Senah KA; Letsa TS; Owusu-Agyei S
Malar J; 2013 May; 12():156. PubMed ID: 23651533
[TBL] [Abstract][Full Text] [Related]
13. Current challenges and proposed solutions to the effective implementation of the RTS, S/AS01 Malaria Vaccine Program in sub-Saharan Africa: A systematic review.
Dimala CA; Kika BT; Kadia BM; Blencowe H
PLoS One; 2018; 13(12):e0209744. PubMed ID: 30596732
[TBL] [Abstract][Full Text] [Related]
14. Integration of the RTS,S/AS01 malaria vaccine into the Essential Programme on Immunisation in western Kenya: a qualitative longitudinal study from the health system perspective.
Hill J; Bange T; Hoyt J; Kariuki S; Jalloh MF; Webster J; Okello G
Lancet Glob Health; 2024 Apr; 12(4):e672-e684. PubMed ID: 38430916
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial.
Asante KP; Abdulla S; Agnandji S; Lyimo J; Vekemans J; Soulanoudjingar S; Owusu R; Shomari M; Leach A; Jongert E; Salim N; Fernandes JF; Dosoo D; Chikawe M; Issifou S; Osei-Kwakye K; Lievens M; Paricek M; Möller T; Apanga S; Mwangoka G; Dubois MC; Madi T; Kwara E; Minja R; Hounkpatin AB; Boahen O; Kayan K; Adjei G; Chandramohan D; Carter T; Vansadia P; Sillman M; Savarese B; Loucq C; Lapierre D; Greenwood B; Cohen J; Kremsner P; Owusu-Agyei S; Tanner M; Lell B
Lancet Infect Dis; 2011 Oct; 11(10):741-9. PubMed ID: 21782519
[TBL] [Abstract][Full Text] [Related]
16. Factors likely to affect community acceptance of a malaria vaccine in two districts of Ghana: a qualitative study.
Meñaca A; Tagbor H; Adjei R; Bart-Plange C; Collymore Y; Ba-Nguz A; Mertes K; Bingham A
PLoS One; 2014; 9(10):e109707. PubMed ID: 25334094
[TBL] [Abstract][Full Text] [Related]
17. Delivery strategies for malaria vaccination in areas with seasonal malaria transmission.
Grant J; Diawara H; Traore S; Koita F; Myers J; Sagara I; Chandramohan D; Dicko A; Greenwood B; Webster J
BMJ Glob Health; 2023 May; 8(5):. PubMed ID: 37147016
[TBL] [Abstract][Full Text] [Related]
18. RTS,S/AS01
Okyere J; Bediako VB; Ackah JA; Acheampong E; Owusu BA; Agbemavi W; Nwameme AU; Kamau EM; Asampong E
Malar J; 2023 Sep; 22(1):260. PubMed ID: 37674197
[TBL] [Abstract][Full Text] [Related]
19. Implementation strategies for the introduction of the RTS,S/AS01 (RTS,S) malaria vaccine in countries with areas of highly seasonal transmission: workshop meeting report.
Merle CS;
Malar J; 2023 Aug; 22(1):242. PubMed ID: 37612716
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with malaria vaccine uptake in Nsanje district, Malawi.
Simbeye AJ; Kumwenda S; Cohee LM; Omondi D; Masibo PK; Wao H; Awandu SS
Malar J; 2024 Apr; 23(1):105. PubMed ID: 38627704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
